BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3467816)

  • 1. Immunoradiometric assay of CA 125 in effusions. Comparison with carcinoembryonic antigen.
    Pinto MM; Bernstein LH; Brogan DA; Criscuolo E
    Cancer; 1987 Jan; 59(2):218-22. PubMed ID: 3467816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CA 72-4 radioimmunoassay in the diagnosis of malignant effusions. Comparison of various tumor markers.
    Ferroni P; Szpak C; Greiner JW; Simpson JF; Guadagni F; Johnston WW; Colcher D
    Int J Cancer; 1990 Sep; 46(3):445-51. PubMed ID: 2394511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic efficiency of carcinoembryonic antigen and CA125 in the cytological evaluation of effusions.
    Pinto MM; Bernstein LH; Rudolph RA; Brogan DA; Rosman M
    Arch Pathol Lab Med; 1992 Jun; 116(6):626-31. PubMed ID: 1616424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic significance of carcinoembryonic antigen levels in serous effusions. Correlation with cytology.
    Whiteside TL; Dekker A
    Acta Cytol; 1979; 23(6):443-8. PubMed ID: 295160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen.
    Bast RC; Klug TL; Schaetzl E; Lavin P; Niloff JM; Greber TF; Zurawski VR; Knapp RC
    Am J Obstet Gynecol; 1984 Jul; 149(5):553-9. PubMed ID: 6204531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoembryonic antigen in effusions. A diagnostic adjunct to cytology.
    Pinto MM; Bernstein LH; Brogan DA; Criscuolo EM
    Acta Cytol; 1987; 31(2):113-8. PubMed ID: 3548190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved specificity of the CA 125 enzyme immunoassay for ovarian carcinomas by use of the ratio of CA 125 to carcinoembryonic antigen.
    Wu JT; Miya T; Knight JA; Knight DP
    Clin Chem; 1988 Sep; 34(9):1853-7. PubMed ID: 2458203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue expression of CA 125 in benign and malignant lesions of ovary and fallopian tube: a comparison with CA 19-9 and CEA.
    Neunteufel W; Breitenecker G
    Gynecol Oncol; 1989 Mar; 32(3):297-302. PubMed ID: 2646183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigen in primary and metastatic ovarian tumors.
    Fleuren GJ; Nap M
    Gynecol Oncol; 1988 Jul; 30(3):407-15. PubMed ID: 2839395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoembryonic antigen (CEA) and carbohydrate determinant 19-9 (CA 19-9) localization in 121 primary and metastatic ovarian tumors: an immunohistochemical study with the use of monoclonal antibodies.
    Charpin C; Bhan AK; Zurawski VR; Scully RE
    Int J Gynecol Pathol; 1982; 1(3):231-45. PubMed ID: 6193072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoassay of the CA 12 5 antigen in ovarian carcinomas: advantages compared with CA 19-9 and CEA.
    Ricolleau G; Chatal JF; Fumoleau P; Kremer M; Douillard JY; Curtet C
    Tumour Biol; 1984; 5(3-4):151-9. PubMed ID: 6594738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor markers in gynecologic diseases].
    Geyer H; Kleine W
    Geburtshilfe Frauenheilkd; 1987 Mar; 47(3):168-72. PubMed ID: 3472991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CA-15.3 assay in effusions: comparison with carcinoembryonic antigen and CA-125 assay and cytologic diagnosis.
    Pinto MM
    Acta Cytol; 1996; 40(3):437-42. PubMed ID: 8669175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen (CEA) and gastrointestinal cancer associated antigen CA 19-9 in bronchioloalveolar carcinomas and pulmonary adenocarcinomas.
    Heikkilä L; Suomalainen RJ; Lindgren J; Jalanko H; Harjula A; Mattila S
    Ann Chir Gynaecol; 1986; 75(5):260-5. PubMed ID: 3030184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Values of carcinoembryonic antigen, elastase 1, and carbohydrate antigen determinant in aspirated pancreatic cystic fluid in the diagnosis of cysts of the pancreas.
    Tatsuta M; Iishi H; Ichii M; Noguchi S; Yamamoto R; Yamamura H; Okuda S
    Cancer; 1986 May; 57(9):1836-9. PubMed ID: 2420441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human alveolar macrophage-56 and carcinoembryonic antigen monoclonal antibodies in the differential diagnosis between primary ovarian and metastatic gastrointestinal carcinomas.
    Fowler LJ; Maygarden SJ; Novotny DB
    Hum Pathol; 1994 Jul; 25(7):666-70. PubMed ID: 8026826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic significance of cancer antigen 125, pancreatic oncofetal antigen, and carcinoembryonic antigen in malignant and tuberculous pleural effusions.
    Niwa Y; Shimokata K
    Jpn J Clin Oncol; 1986 Mar; 16(1):3-8. PubMed ID: 3009919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New prospects in the combined use of tumor markers in epithelial neoplasms of the ovary].
    Indraccolo SR; Cecchi A; Thodos A; Brandi S; Carta G
    Ann Ostet Ginecol Med Perinat; 1991; 112(1):36-40. PubMed ID: 1929097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative measurement of ovarian carcinoma antigen and carcinoembryonic antigen in the serum of ovarian cancer.
    Yuan CC; Ng HT; Tsai LC; Jeng FS; Yeh SH; Tsai YC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):190-7. PubMed ID: 3480793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.